Brand / Product	Market	Holder	Status	Expires
MYDEKLA 60 TABLETS (Each film-coated tablet contains Daclatasvir Dihydrochloride 60mg)	🇬🇭Ghana	—	active	Mar 2031
MYDEKLA 60 TABLETS (Each film-coated tablet contains Daclatasvir Dihydrochloride 60mg)	🇬🇭Ghana	—	active	Mar 2031
Daclavir Film Coated Tablet	🇷🇼Rwanda	European Egyptian Pharmaceutical Industries	active	Dec 2030
Mydekla 60 Tablets Film-coated Tablets	🇿🇲Zambia	Mylan Laboratories Limited	active	Jul 2030
MYDEKLA 60 TABLET, COATED; ORAL	🇿🇼Zimbabwe	MYLAN LABORATORIES LIMITED	active	May 2029
MYDEKLA 60 Film-Coated Tablet	🇰🇪Kenya	Mylan Pharmaceuticals Private Limited	active	Sept 2027
VIRDAC_30 30MG TABLET TABLET	🇲🇼Malawi	—	expired	Jun 2021
VIRDAC_60 60MG TABLET TABLET	🇲🇼Malawi	—	expired	Jun 2021
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	HETERO DRUGS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	HETERO LABS LTD	active	—
MyHep DVIR Film Coated Tablet	🇹🇿Tanzania	Mylan Laboratories Limited	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	HETERO LABS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	HETERO DRUGS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	MYLAN LABORATORIES LIMITED	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	MYLAN LABORATORIES LIMITED	active	—
DACLAVIRDIN Film coated tablets	🇹🇿Tanzania	EVA Pharma for Pharmaceuticals and Medical Appliances	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	HETERO LABS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	HETERO DRUGS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	MYLAN LABORATORIES LIMITED	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY TABLETS	🇺🇬Uganda	HETERO LABS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	HETERO DRUGS LTD	active	—
DACLATASVIR DIHYDROCHLORIDE ORAL SOLID ORDINARY FILM- COATED TABLETS	🇺🇬Uganda	MYLAN LABORATORIES LIMITED	active	—

DACLATASVIR DIHYDROCHLORIDE in Africa — Regulatory Overview

DACLATASVIR DIHYDROCHLORIDE is registered across 8 African markets with 22 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including Uganda, Malawi, Ghana, Tanzania and 4 more. AfricaRegulatory refreshes this data daily from official government sources.

Of the 22 registrations, 20 (91%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.